54027-8 |
Lamin Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Lamin Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
IF: Lamin antibodies pos. |
|
|
|
|
|
SERO |
|
54027-8 |
|
IF |
|
|
Both |
|
|
|
0 |
Lamin Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54028-6 |
Lamin Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Lamin Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
IF: Lamin antibodies 1:160. |
|
|
|
|
|
SERO |
|
54028-6 |
|
IF |
|
|
Both |
|
|
|
0 |
Lamin Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.26 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
54029-4 |
Soluble liver Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Soluble liver Ab [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
SLA/LP Ab: positive. |
|
|
|
|
|
SERO |
|
54029-4 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Soluble liver Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytokeratin; Hepatology; Liver; Liver-pancreas antigen; O-phosphoseryl-tRNA(Sec) selenium transferase; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SLA; Soluble liver antigen; SR |
2.58 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5403-1 |
Varicella zoster virus Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ACU/mL; EIA Index |
|
|
|
|
|
|
MICRO |
|
5403-1 |
|
IA |
|
|
Both |
|
|
|
0 |
VZV IgG Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; SR; SUDS; UniversalLabOrders; VZ; VZV; Zoster |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
214 |
54030-2 |
Smith extractable nuclear B Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Smith extractable nuclear B Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
SmB antibody pos. |
|
|
|
|
|
SERO |
|
54030-2 |
|
|
|
|
Both |
|
|
|
0 |
ENA SM-B Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ENA; ENA SM; ENA SM-B; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SmB; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54031-0 |
Smith extractable nuclear D Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Smith extractable nuclear D Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
SmD antibody: pos. |
|
|
|
|
|
SERO |
|
54031-0 |
|
|
|
|
Both |
|
|
|
0 |
ENA SM-D Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dextro; ENA; ENA SM; ENA SM-D; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh; Rhesus; Screen; Serology; Serum; SM; SmD; SR |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54032-8 |
U1 small nuclear ribonucleoprotein A Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
RNP-A antibody: positive. |
|
|
|
|
|
SERO |
|
54032-8 |
|
|
|
|
Both |
|
|
|
0 |
U1 snRNP-A Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Mixed connective tissue disorder; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Raynaud's Disease; Ribonuclear protein; RNP; Screen; Serology; Serum; snRNP; snRPA; SR; Systemic lupus erythematosus; U1 RNP; U1 snRNP; U1 snRNP-A; U1RNP |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54033-6 |
Rickettsia spotted fever group Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
Not detected;Detected |
|
|
|
|
|
MICRO |
|
54033-6 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Rick SF Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rick SF; Ricket; Rickettsial; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54034-4 |
Anaplasma phagocytophilum Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
Not detected;Detected |
|
|
|
|
|
MICRO |
|
54034-4 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
A phagocytoph Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; Human granulocytic ehrlichiosis; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54035-1 |
Ehrlichia chaffeensis Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
Not detected;Detected |
|
|
|
|
|
MICRO |
|
54035-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
E chaffeensis Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; E chaffeensis; HME; Human monocytic ehrlichiosis; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54036-9 |
Western equine encephalitis virus RNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Western equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
Answer List Definition List Identifier: Detected Long Name: Detected Defined Answers for List 260373001|Detected|SNOMED CT |
|
|
|
|
|
MICRO |
|
54036-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
WEEV RNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Enc; Enceph; Encephalomyelitis; Equin; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Togavirus; Transcription mediated amplification; Unspecified; WEE virus; WEEV; West |
2.69 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
54037-7 |
HEDIS 2009 panel |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54037-7 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 Pnl |
|
|
|
N |
|
HEDIS 2009 Pnl; Pan; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.75 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54038-5 |
HEDIS 2009-2013 Codes to identify cervical cancer screening tests (CCS-A) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009-2013 Codes to identify cervical cancer screening tests (CCS-A) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54038-5 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009-13 CCS-A |
|
|
|
N |
|
Asympt; Asymptomatic; Cerv; HEDIS 2009-13 CCS-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54039-3 |
HEDIS 2009-2011 Codes to identify HbA1c tests (CDC-D) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009-2011 Codes to identify HbA1c tests (CDC-D) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54039-3 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009-2011CDC-D |
|
|
|
N |
|
Dextro; HEDIS 2009-2011CDC-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5404-9 |
Varicella zoster virus Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5404-9 |
|
IA |
|
|
Both |
|
|
|
0 |
VZV IgM Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; SR; SUDS; UniversalLabOrders; VZ; VZV; Zoster |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL;{Index_val} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
54040-1 |
HEDIS 2009 Codes to identify LDLc screening (CDC-H) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify LDLc screening (CDC-H) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54040-1 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CDC-H |
|
|
|
N |
|
Asympt; Asymptomatic; HEDIS 2009 CDC-H; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54041-9 |
HEDIS 2009 Codes to identify nephropathy screening tests (CDC-J) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify nephropathy screening tests (CDC-J) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54041-9 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CDC-J |
|
|
|
N |
|
Asympt; Asymptomatic; HEDIS 2009 CDC-J; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54042-7 |
HEDIS 2009 Codes to identify evidence of nephropathy (CDC-K) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify evidence of nephropathy (CDC-K) |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54042-7 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CDC-K |
|
|
|
N |
|
HEDIS 2009 CDC-K; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.75 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54043-5 |
HEDIS 2009 Codes to identify sexually active women (CHL-B) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify sexually active women (CHL-B) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54043-5 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CHL-B |
|
|
|
N |
|
HEDIS 2009 CHL-B; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54044-3 |
HEDIS 2009 Codes to identify Chlamydia screening (CHL-C) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify Chlamydia screening (CHL-C) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54044-3 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CHL-C |
|
|
|
N |
|
Asympt; Asymptomatic; Chlam; Chlamid; HEDIS 2009 CHL-C; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54045-0 |
HEDIS 2009, 2010 Codes to identify exclusions (CHL-D) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009, 2010 Codes to identify exclusions (CHL-D) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54045-0 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009-10 CHL-D |
|
|
|
N |
|
Dextro; HEDIS 2009-10 CHL-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54046-8 |
HEDIS 2009 Codes to identify LDLc screening (CMC-D) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify LDLc screening (CMC-D) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54046-8 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CMC-D |
|
|
|
N |
|
Asympt; Asymptomatic; Dextro; HEDIS 2009 CMC-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54047-6 |
HEDIS 2009 Codes to identify colorectal cancer screening (COL-A) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify colorectal cancer screening (COL-A) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54047-6 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 COL-A |
|
|
|
N |
|
Asympt; Asymptomatic; HEDIS 2009 COL-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54048-4 |
HEDIS 2009 Codes to identify group A Streptococcus tests (CWP-D) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009 Codes to identify group A Streptococcus tests (CWP-D) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54048-4 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009 CWP-D |
|
|
|
N |
|
Dextro; HEDIS 2009 CWP-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Strep; Strept |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54049-2 |
HEDIS 2009-2013 Codes to identify lead (LSC-A) |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2009-2013 Codes to identify lead (LSC-A) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
54049-2 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2009-13 LSC-A |
|
|
|
N |
|
HEDIS 2009-13 LSC-A; Painter's colic; Pan; Panel; PANEL.HEDIS; Panl; PB; Plumbism; Pnl; Point in time; Random |
2.67 |
2.26 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |